Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis

Ribosomal Proteins Control Tumor Suppressor Pathways in Response to Nucleolar Stress

(2019) Frédéric Lessard et al.   BIOESSAYS

Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment

(2018) Daniela Belloni et al.   HAEMATOLOGICA

Flavonoids Luteolin and Quercetin Inhibit RPS19 and contributes to metastasis of cancer cells through c-Myc reduction

(2018) Ku-Chung Chen et al.   JOURNAL OF FOOD AND DRUG ANALYSIS

Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study

(2018) Subhayan Chattopadhyay et al.   MOLECULAR MEDICINE

The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression

(2018) Mina Ali et al.   Nature Communications

Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment

(2018) Daniela Belloni et al.   HAEMATOLOGICA

B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma

(2018) Li Li et al.   BLOOD

Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis

(2018) Fang Chen et al.   Cancer Medicine

Is immunotherapy here to stay in multiple myeloma?

(2017) Paula Rodríguez-Otero et al.   HAEMATOLOGICA

Syk inhibitors in clinical development for hematological malignancies

(2017) Delong Liu et al.   Journal of Hematology & Oncology

Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials

(2017) P Arana et al.   LEUKEMIA

B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia

(2017) Hima V. Vangapandu et al.   MOLECULAR CANCER RESEARCH

SYK kinase mediates brown fat differentiation and activation

(2017) Marko Knoll et al.   Nature Communications

Is immunotherapy here to stay in multiple myeloma?

(2017) Paula Rodríguez-Otero et al.   HAEMATOLOGICA

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

(2016) P. Sonneveld et al.   BLOOD

Myeloid-derived suppressor cells: The green light for myeloma immune escape

(2016) Ehsan Malek et al.   BLOOD REVIEWS

Cadherin-11 (CDH11) expression in the peripheral blood of patients with active Multiple Myeloma

(2016) Panagiotis F. Christopoulos et al.   BRITISH JOURNAL OF HAEMATOLOGY

Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies

(2016) Camille Guillerey et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma

(2016) P. Neri et al.   CLINICAL CANCER RESEARCH

Immune Therapies in Multiple Myeloma

(2016) Shaji K. Kumar et al.   CLINICAL CANCER RESEARCH

RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

(2016) I J F Hofman et al.   LEUKEMIA

Differentiation stage of myeloma plasma cells: biological and clinical significance

(2016) B Paiva et al.   LEUKEMIA

The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs

(2015) L E Franssen et al.   BONE MARROW TRANSPLANTATION

From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration

(2015) Joschka Lorenz et al.   BRITISH JOURNAL OF HAEMATOLOGY

PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma

(2015) B Paiva et al.   LEUKEMIA

Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma

(2015) Yunpeng Sun et al.   OncoTargets and Therapy

Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies

(2014) L. Lopez-Corral et al.   HAEMATOLOGICA

How antibodies use complement to regulate antibody responses

(2014) Anna Sörman et al.   MOLECULAR IMMUNOLOGY

mTORC1 signaling controls multiple steps in ribosome biogenesis

(2014) Valentina Iadevaia et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Immunologic microenvironment and personalized treatment in multiple myeloma

(2013) Marco Rossi et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Preclinical models of multiple myeloma: a critical appraisal

(2013) Julia Schüler et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Cancer Genome Landscapes

(2013) B. Vogelstein et al.   SCIENCE

Proteasome inhibitors in multiple myeloma: 10 years later

(2012) P. Moreau et al.   BLOOD

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Multiple Myeloma

(2011) Antonio Palumbo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Classical and/or alternative NF- B pathway activation in multiple myeloma

(2010) Y. N. Demchenko et al.   BLOOD

Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia

(2010) M. Buchner et al.   BLOOD

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

Peroxisome proliferator-activated receptor γ agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells

(2009) Nassera Aouali et al.   BRITISH JOURNAL OF HAEMATOLOGY

Epigenetic Silencing of the Tetraspanin CD9 during Disease Progression in Multiple Myeloma Cells and Correlation with Survival

(2008) E. De Bruyne et al.   CLINICAL CANCER RESEARCH